The Iranian Tissue Product Company was founded in 2012 as Iran’s first specialized human tissue processing center (Allograft), with scientific and operational backing from experts and faculty members of Tehran University of Medical Sciences. Operating under the supervision of the university’s Medical Equipment Development Center, the company has achieved remarkable progress in the field of allograft production and distribution. By localizing advanced technologies and adhering to global standards, it has successfully developed a wide range of high-quality allograft products.

The company holds all required operational and manufacturing licenses issued by the National Medical Device Directorate of the Iranian Food and Drug Administration, as well as the Ministry of Industry, Mine, and Trade. In addition, it has obtained ISO 13485:2016 certification from KGS validation company, confirming the high level of its quality management system.

Today, the company’s allograft products are recognized as the gold standard for reconstruction of soft and hard tissue defects. These human-derived materials are applied as scaffolds, biologic dressings, and volumizing agents across various medical disciplines including orthopedic and spinal surgeries, burn and plastic reconstruction, ENT and rhinoplasty, maxillofacial surgery, dentistry, and dermatology.

Because the biological materials are obtained through voluntary donation, the final product cost only covers processing and manufacturing, making the treatments both economical and accessible. The quality, safety, and efficacy of all products are ensured through strict adherence to the American Association of Tissue Banks (AATB) standards, constant oversight by regulatory authorities, and the company’s comprehensive quality assurance and control systems, which rely on carefully selected healthy tissue donors from within Iran.